Searched for
PFIZER LIMITED SHARES
Scanning cancer, up close & personal: A revolution is underway in cancer diagnosisA gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...- Pfizer weighs sweeter offer for Metsera after Judge blocks bid to halt Novo Nordisk’s $10 billion takeoverPfizer is increasing its offer for Metsera. This comes after a judge rejected Pfizer's attempt to stop rival Novo Nordisk's bid. Pfizer's d...
- Pfizer shares zoom nearly 9% after marketing and supply agreement with Mylan PharmaceuticalsPfizer shares surged 8.6% to Rs 4,448.35 after announcing a marketing and supply agreement with Mylan Pharmaceuticals for Ativan and Pacita...
- CCI approves BC Asia Investments' stake acquisition in IIFL Wealth ManagementBC Asia Investments X Ltd is indirectly held by Bain Capital Investors LLC (Bain Private Equity), Bain Capital Credit Member LLC and Bain C...
- How does Merck's COVID-19 pill compare to Pfizer's?Merck in November said its full trial results showed that molnupiravir lowered the chance of hospitalization or death by about 30% in patie...
- Market Movers: What drove investors to cement producers’ counters today?Cement sector was largely ignored by investors after the second wave buying rush because of the uneven demand environment as well as rising...
- Japan stocks end lower as dour earnings hit construction firmsThe Nikkei share average fell 0.35% to 29,507.05, despite Wall Street finishing strong on Friday, slipping from a one-month high hit on Thu...
- Pfizer says antiviral pill cuts risk of severe COVID-19 by 89%Pfizer said it plans to submit interim trial results for its pill, which is given in combination with an older antiviral called ritonavir, ...
- Moderna's single-dose COVID-19 vaccine in India likely next year; Pfizer ready with 5 crore doses for 2021Two rounds of high-level meetings chaired by the Cabinet Secretary were held last week on the availability of vaccines in the global as wel...
- Market Movers: Pfizer soars on likely Covid vaccine nod; TCS sinks on profit bookingShares of Tata Motors jumped nearly 6 per cent after arm Jaguar Land Rover said that it is likely to report significant free cash flow in t...
- Pfizer/BioNTech say COVID-19 vaccine likely to prevent asymptomatic infectionThe companies also said the latest analysis of the Israeli data shows the vaccine was 97% effective in preventing symptomatic disease, seve...
- WHO praises 'phenomenal' promise of COVID vaccinesBritain approved Pfizer Inc's COVID-19 vaccine, developed with Germany's BioNTech, outpacing the world in the race to begin the most crucia...
- CCI clears Micromax-Madison India deal, 3 others get go-aheadIn a tweet, the watchdog said it has approved "acquisition of equity stake in Micromax Informatics Limited by Madison India Opportunities T...
- Pfizer announces completion of merger with WyethPfizer today announced completion of the merger with Wyeth Ltd, thereby placing the former among the top ten pharmaceutical companies in In...
- Stocks in news: Infosys, Pfizer, Axis Bank, FTIL, Ranbaxy, MCXTraders must use upmove in the market as an opportunity to reduce long positions, say analysts. Here are stocks that are likely to be in ac...
- Wyeth surges 20%; hits upper limit on merger plans with PfizerShares of Wyeth zoomed by 20 per cent to hit the upper circuit limit after the company announced its plan to merge with Pfizer.
- Pfizer India takes National Pharmaceutical Pricing Authority to court over Benadryl price cutPfizer India Ltd has taken the drug price regulator to court for reducing the price of a popular cough syrup, Benadryl , a brand it no long...
- Ranbaxy's party may be spoiled by too many playersWhile Ranbaxy did secure the final approval of the USFDA to launch the generic version of Lipitor on time, there are too many players to sp...
- Claris gets nod for Rs 300-crore IPOClaris Lifesciences Ltd, has finally received approval from SEBI for its maiden public issue to raise Rs 300 crore.
- Wyeth to boost Pfizer's share in Indian marketPfizer's $68-billion buyout of Wyeth may help catapult its local subsidiary into the top ten league of Indian drugmakers.
Load More
